Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Capreomycin
Drug ID BADD_D00350
Description Cyclic peptide antibiotic similar to viomycin. It is produced by Streptomyces capreolus.
Indications and Usage Used in the treatment of tuberculosis in combination with other drugs.
Marketing Status approved
ATC Code J04AB30
DrugBank ID DB00314
KEGG ID D07607
MeSH ID D002207
PubChem ID 3000502
TTD Drug ID D0E7MV
NDC Product Code Not Available
UNII 232HYX66HC
Synonyms Capreomycin | Capromycin | Capreomycin Sulfate | Capastat
Chemical Information
Molecular Formula C50H88N28O15
CAS Registry Number 11003-38-6
SMILES CC1C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)NC(C(=O)NCC(C(=O)N1)N)C2CCN=C(N2)N)CNC(=O)CC(C CCN)N.C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CNC(=O)CC(C CCN)N)CO)N)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abscess sterile08.01.05.008--Not Available
Bromosulphthalein test abnormal13.03.04.021--Not Available
Deafness04.02.01.001--Not Available
Electrolyte imbalance14.05.01.002--Not Available
Eosinophilia01.02.04.001--
Injection site haemorrhage24.07.01.010; 12.07.03.005; 08.02.03.005--Not Available
Injection site induration12.07.03.007; 08.02.03.007--Not Available
Injection site pain12.07.03.011; 08.02.03.010--Not Available
Leukocytosis01.02.01.002--
Leukopenia01.02.02.001--Not Available
Nephropathy toxic20.05.03.002; 12.03.01.010--Not Available
Pyrexia08.05.02.003--
Rash maculo-papular23.03.13.004--
Thrombocytopenia01.08.01.002--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Urticaria23.04.02.001; 10.01.06.001--
Vertigo17.02.12.002; 04.04.01.003--
The 1th Page    1    Total 1 Pages